Catalyst Intel Subscribe

Trial results

$VIR — VIR-EVENT-2026

Vir Biotechnology, Inc. (VIR): trial results in CHD, 2026.

Research by Catalyst Intel

The catalyst

"Topline data from the pivotal ECLIPSE 1 trial are expected in the fourth quarter of 2026."

— Vir Biotechnology, 10-Q filed 2026-11-04 · the filing. Checked word for word against the stored document when this page was built; a sentence that did not check out would not be here.

Event id
VIR-EVENT-2026
Company
Vir Biotechnology, Inc.
Kind
Trial results
Indication
CHD
Window
2026-01-01 – 2026-12-31
Status
dropped

The bar

No bar has been published for this event yet.

Verdicts

No verdict has been published for this event yet.